Skip to main content
Erschienen in: Tumor Biology 7/2016

27.01.2016 | Original Article

SUSD2 is frequently downregulated and functions as a tumor suppressor in RCC and lung cancer

verfasst von: Yingying Cheng, Xiaolin Wang, Pingzhang Wang, Ting Li, Fengzhan Hu, Qiang Liu, Fan Yang, Jun Wang, Tao Xu, Wenling Han

Erschienen in: Tumor Biology | Ausgabe 7/2016

Einloggen, um Zugang zu erhalten

Abstract

Sushi domain containing 2 (SUSD2) is type I membrane protein containing domains inherent to adhesion molecules. There have been few reported studies on SUSD2, and they have mainly focused on breast cancer, colon cancer, and HeLa cells. However, the expression and function of SUSD2 in other cancers remain unclear. In the present study, we conducted an integrated bioinformatics analysis based on the array data from the GEO database and found a significant downregulation of SUSD2 in renal cell carcinoma (RCC) and lung cancer. Western blotting and quantitative RT-PCR (qRT-PCR) confirmed that SUSD2 was frequently decreased in RCC and lung cancer tissues compared with the corresponding levels in normal adjacent tissues. The restoration of SUSD2 expression inhibited the proliferation and clonogenicity of RCC and lung cancer cells, whereas the knockdown of SUSD2 promoted A549 cell growth. Our findings suggested that SUSD2 functions as a tumor suppressor gene (TSG) in RCC and lung cancer.
Literatur
1.
Zurück zum Zitat Sugahara T, Yamashita Y, Shinomi M, Yamanoha B, Iseki H, Takeda A, et al. Isolation of a novel mouse gene, mSVS-1/SUSD2, reversing tumorigenic phenotypes of cancer cells. Cancer Sci. 2007;6:900–8.CrossRef Sugahara T, Yamashita Y, Shinomi M, Yamanoha B, Iseki H, Takeda A, et al. Isolation of a novel mouse gene, mSVS-1/SUSD2, reversing tumorigenic phenotypes of cancer cells. Cancer Sci. 2007;6:900–8.CrossRef
2.
Zurück zum Zitat Sugahara T, Yamashita Y, Shinomi M, Isobe Y, Yamanoha B, Iseki H, et al. Von Willebrand factor type D domain mutant of Blackwell Publishing Asia SVS-1/SUSD2, vWD(m), induces apoptosis in HeLa cells. Cancer Sci. 2007;6:909–15.CrossRef Sugahara T, Yamashita Y, Shinomi M, Isobe Y, Yamanoha B, Iseki H, et al. Von Willebrand factor type D domain mutant of Blackwell Publishing Asia SVS-1/SUSD2, vWD(m), induces apoptosis in HeLa cells. Cancer Sci. 2007;6:909–15.CrossRef
3.
Zurück zum Zitat Watson AP, Evans RL, Egland KA. Multiple functions of sushi domain containing 2 (SUSD2) in breast tumorigenesis. Mol Cancer Res. 2013;11:74–85.CrossRefPubMed Watson AP, Evans RL, Egland KA. Multiple functions of sushi domain containing 2 (SUSD2) in breast tumorigenesis. Mol Cancer Res. 2013;11:74–85.CrossRefPubMed
4.
Zurück zum Zitat Pan W, Cheng Y, Zhang H, Liu B, Mo X, Li T, et al. CSBF/C10orf99, a novel potential cytokine, inhibits colon cancer cell growth through inducing G1 arrest. Sci Rep. 2014;4:6812.CrossRefPubMedPubMedCentral Pan W, Cheng Y, Zhang H, Liu B, Mo X, Li T, et al. CSBF/C10orf99, a novel potential cytokine, inhibits colon cancer cell growth through inducing G1 arrest. Sci Rep. 2014;4:6812.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Letouzey V, Tan KS, Deane JA, Ulrich D, Gurung S, Ong YR, et al. Isolation and characterisation of mesenchymal Stem/Stromal cells in the ovine endometrium. Plos One. 2015;10:e0127531.CrossRefPubMedPubMedCentral Letouzey V, Tan KS, Deane JA, Ulrich D, Gurung S, Ong YR, et al. Isolation and characterisation of mesenchymal Stem/Stromal cells in the ovine endometrium. Plos One. 2015;10:e0127531.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Benz K, Stippich C, Freudigmann C, Mollenhauer JA, Aicher WK, et al. Maintenance of “stem cell” features of cartilage cell sub-populations during in vitro propagation. J Transl Med. 2013;11:27.CrossRefPubMedPubMedCentral Benz K, Stippich C, Freudigmann C, Mollenhauer JA, Aicher WK, et al. Maintenance of “stem cell” features of cartilage cell sub-populations during in vitro propagation. J Transl Med. 2013;11:27.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Ulrich D, Tan KS, Deane J, Schwab K, Cheong A, Rosamilia A, et al. Mesenchymal stem/stromal cells in post-menopausal endometrium. Hum Reprod. 2014;29:1895–905.CrossRefPubMed Ulrich D, Tan KS, Deane J, Schwab K, Cheong A, Rosamilia A, et al. Mesenchymal stem/stromal cells in post-menopausal endometrium. Hum Reprod. 2014;29:1895–905.CrossRefPubMed
8.
Zurück zum Zitat Sivasubramaniyan K, Harichandan A, Schumann S, Sobiesiak M, Lengerke C, Maurer A, et al. Prospective isolation of mesenchymal stem cells from human bone marrow using novel antibodies directed against Sushi domain containing 2. Stem Cells Dev. 2013;22:1944–54.CrossRefPubMed Sivasubramaniyan K, Harichandan A, Schumann S, Sobiesiak M, Lengerke C, Maurer A, et al. Prospective isolation of mesenchymal stem cells from human bone marrow using novel antibodies directed against Sushi domain containing 2. Stem Cells Dev. 2013;22:1944–54.CrossRefPubMed
9.
Zurück zum Zitat Fang Z, Tang Y, Fang J, Zhou Z, Xing Z, Guo Z, et al. Simvastatin inhibits renal cancer cell growth and metastasis via AKT/mTOR, ERK and JAK2/STAT3 pathway. Plos One. 2013;8:e62823.CrossRefPubMedPubMedCentral Fang Z, Tang Y, Fang J, Zhou Z, Xing Z, Guo Z, et al. Simvastatin inhibits renal cancer cell growth and metastasis via AKT/mTOR, ERK and JAK2/STAT3 pathway. Plos One. 2013;8:e62823.CrossRefPubMedPubMedCentral
10.
11.
12.
Zurück zum Zitat Jonasch E, Futreal PA, Davis IJ, Bailey ST, Kim WY, Brugarolas J, et al. State of the science: an update on renal cell carcinoma. Mol Cancer Res. 2012;10:859–80.CrossRefPubMedPubMedCentral Jonasch E, Futreal PA, Davis IJ, Bailey ST, Kim WY, Brugarolas J, et al. State of the science: an update on renal cell carcinoma. Mol Cancer Res. 2012;10:859–80.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Leibovich BC, Blute ML, Cheville JC, Lohse CM, Frank I, Kwon ED, et al. Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. Cancer. 2003;97:1663–71.CrossRefPubMed Leibovich BC, Blute ML, Cheville JC, Lohse CM, Frank I, Kwon ED, et al. Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. Cancer. 2003;97:1663–71.CrossRefPubMed
14.
15.
Zurück zum Zitat Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006;24:2137–50.CrossRefPubMed Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006;24:2137–50.CrossRefPubMed
16.
Zurück zum Zitat Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–917.CrossRefPubMed Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–917.CrossRefPubMed
17.
Zurück zum Zitat Zhu D, Chen H, Yang X, Chen W, Wang L, Xu J, et al. MiR-32 functions as a tumor suppressor and directly targets SOX9 in human non-small cell lung cancer. Onco Targets Ther. 2015;8:1773–83.CrossRefPubMedPubMedCentral Zhu D, Chen H, Yang X, Chen W, Wang L, Xu J, et al. MiR-32 functions as a tumor suppressor and directly targets SOX9 in human non-small cell lung cancer. Onco Targets Ther. 2015;8:1773–83.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Wang P, Qi H, Song S, Li S, Huang N, Han W, et al. ImmuCo: a database of gene co-expression in immune cells. Nucleic Acids Res. 2015;43:D1133–9.CrossRefPubMed Wang P, Qi H, Song S, Li S, Huang N, Han W, et al. ImmuCo: a database of gene co-expression in immune cells. Nucleic Acids Res. 2015;43:D1133–9.CrossRefPubMed
20.
Zurück zum Zitat Wang Y, Li J, Cui Y, Li T, Ng KM, Geng H, et al. CMTM3, located at the critical tumor suppressor locus 16q22.1, is silenced by CpG methylation in carcinomas and inhibits tumor cell growth through inducing apoptosis. Cancer Res. 2009;69:5194–201.CrossRefPubMed Wang Y, Li J, Cui Y, Li T, Ng KM, Geng H, et al. CMTM3, located at the critical tumor suppressor locus 16q22.1, is silenced by CpG methylation in carcinomas and inhibits tumor cell growth through inducing apoptosis. Cancer Res. 2009;69:5194–201.CrossRefPubMed
21.
Zurück zum Zitat Li T, Cheng Y, Wang P, Wang W, Hu F, Mo X, et al. CMTM4 is frequently downregulated and functions as a tumour suppressor in clear cell renal cell carcinoma. J Exp Clin Canc Res. 2015;34:122.CrossRef Li T, Cheng Y, Wang P, Wang W, Hu F, Mo X, et al. CMTM4 is frequently downregulated and functions as a tumour suppressor in clear cell renal cell carcinoma. J Exp Clin Canc Res. 2015;34:122.CrossRef
22.
23.
Metadaten
Titel
SUSD2 is frequently downregulated and functions as a tumor suppressor in RCC and lung cancer
verfasst von
Yingying Cheng
Xiaolin Wang
Pingzhang Wang
Ting Li
Fengzhan Hu
Qiang Liu
Fan Yang
Jun Wang
Tao Xu
Wenling Han
Publikationsdatum
27.01.2016
Verlag
Springer Netherlands
Erschienen in
Tumor Biology / Ausgabe 7/2016
Print ISSN: 1010-4283
Elektronische ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-015-4734-y

Weitere Artikel der Ausgabe 7/2016

Tumor Biology 7/2016 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.